PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 31 results · Data & Publications · CNS & Neurology  · Clear
🔒 Subscribers only
AUTH/3544/7/21
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
An anonymous, contactable complainant alleged that between July 2020 and June 2021 Lundbeck sales representatives were not briefed on how often health professionals could be called upon.The complai…
Clauses: NONE
🔒 Subscribers only
AUTH/3534/7/21
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Janssen
Astellas complained about a Janssen Medical Cloud webpage titled “Zytiga Quality of Life” promoting Zytiga (abiraterone acetate) in mCRPC. The page presented multiple QoL/HRQoL claims and chart…
Clauses: NONE
🔒 Subscribers only
AUTH/3218/6/19
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka UK breached ABPI Code over Abilify Maintena detail aid
An anonymous, contactable ex-employee complained about an electronic detail aid for Abilify Maintena (aripiprazole) titled “Take the next step in the disease journey with Abilify Maintena” (ref…
Clauses: NONE
🔒 Subscribers only
AUTH/3001/12/17
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Sunovion
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Latuda.The complaint was received on 20 December 2017 under the 2016 ABPI Code.
Clauses: NONE
🔒 Subscribers only
AUTH/2904/11/16
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A matter was considered by the PMCPA involving the Director and Lundbeck.The case related to clinical trial disclosure for Selincro.Complaint received: 06 December 2016.
Clauses: NONE
🔒 Subscribers only
AUTH/2745/1/15
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Shire
A chief pharmacist/director of pharmacy services at an NHS foundation trust complained about how a communications agency (working for Shire) approached a consultant about her ADHD transition servic…
Clauses: NONE
🔒 Subscribers only
AUTH/2788/8/15
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Prescribing Adviser v Pfizer (AUTH/2788/8/15) – Paying for a Lyrica switch
A prescribing adviser complained about Pfizer in relation to “paying for a Lyrica switch”.The complaint was received on 10 August 2015.
Clauses: NONE
🔒 Subscribers only
AUTH/2766/5/15
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Eisai
A matter was raised by the PMCPA Director under Paragraph 5.1 regarding clinical trial disclosure for Fycompa.The case was assessed under the 2015 ABPI Code of Practice framework.The PMCPA conclude…
Clauses: NONE
🔒 Subscribers only
AUTH/2704/3/14
Data & Publications Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Flynn Pharma
A medicines management pharmacist complained about a Flynn Pharma Ltd advertisement for Circadin (melatonin) in Prescriber (Vol 25 issue 1/2, January 2014; ref Circ/ADV/13/0483).The ad stated: “C…
Clauses: 9.1,26.1
🔒 Subscribers only
AUTH/2700/2/14
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Novartis
A nurse complained about a Gilenya advertisement appearing in a lay publication.The complaint was received by the PMCPA on 10 February 2014.The case was completed on 21 March 2014.The PMCPA conclud…
Clauses: NONE
🔒 Subscribers only
AUTH/2493/3/12
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
AstraZeneca advisory board invitations
A general practitioner received a three-page faxed invitation (via a market research agency) to participate in an AstraZeneca advisory board.The fax pack included invitations/letters addressed inco…
Clauses: NONE
🔒 Subscribers only
AUTH/2472/1/12
Data & Publications Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Flynn Pharma
Shire complained about a four-page A5 promotional leavepiece for Medikinet XL (methylphenidate prolonged release) issued by Flynn Pharma (ref MXL/LVP/11/0038).The leavepiece targeted treatment of c…
Clauses: 9.1,26.1
🔒 Subscribers only
AUTH/2432/8/11
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Napp v Grünenthal
Napp complained about two claims in a 6-page, gate-folded leavepiece (ref P10 0140) used by Grünenthal to promote Palexia SR (tapentadol prolonged release) for severe chronic pain in adults manage…
Clauses: NONE
🔒 Subscribers only
AUTH/2466/12/11
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A complaint was made by a Head of Medicines Management about a health professional letter concerning Cipramil.The case was reviewed by the PMCPA.The PMCPA concluded the matter was outwith the scope…
Clauses: NONE
🔒 Subscribers only
AUTH/2358/9/10
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Anonymous v Genus
An anonymous complainant challenged a Genus journal advertisement for APO-go (apomorphine hydrochloride) that stated: “Pd [Parkinson’s disease] specialist Nurse Advisors in APO-go (NAAs) – de…
Clauses: NONE
🔒 Subscribers only
AUTH/2369/11/10
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Abbott Healthcare v Genus
Abbott Healthcare complained about Genus Pharmaceuticals’ patient materials for APO-go (apomorphine) used in Parkinson’s disease.Materials included two patient booklets: Introduction to APO-go …
Clauses: NONE
🔒 Subscribers only
AUTH/2268/9/09
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
ProStrakan
Cephalon complained that a ProStrakan advertisement for Abstral (sublingual fentanyl citrate) appeared in the BMJ on 12 September 2009, despite undertakings given in earlier cases (AUTH/2207/2/09 a…
Clauses: NONE
🔒 Subscribers only
AUTH/2253/7/09
Data & Publications Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Janssen-Cilag
A consultant psychiatrist complained about promotion of Risperdal Consta (prolonged release risperidone) by Janssen-Cilag.The representative showed a PowerPoint/electronic detail aid section discus…
Clauses: 9.1
🔒 Subscribers only
AUTH/2245/6/09
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A Primary Care Trust (PCT) prescribing support unit complained about a Lundbeck letter about Cipralex (escitalopram) sent to a hospital physician (ref 0409/ESC/342/905).The PCT newsletter said esci…
Clauses: NONE
🔒 Subscribers only
AUTH/2241/6/09
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lilly
Two consultants in child and adolescent psychiatry complained about Lilly’s Strattera (atomoxetine) Support Service and a letter asking clinicians to recruit patients.They alleged the service inv…
Clauses: NONE
🔒 Subscribers only
AUTH/2259/8/09
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Pfizer breached undertaking and misled with Champix comparative and NHS-derived charts
Johnson & Johnson complained about Pfizer’s promotion of Champix (varenicline) via a leavepiece (ref CHA693) and a GP journal advertisement (ref CHA752a). The leavepiece compared Champix with…
Clauses: NONE
🔒 Subscribers only
AUTH/2235/5/09
Data & Publications Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
ProStrakan
Cephalon complained about a revised UK promotional campaign for Abstral (sublingual fentanyl citrate tablet) issued by ProStrakan, following an earlier PMCPA ruling against a “from 10 minutes” …
Clauses: 9.1
🔒 Subscribers only
AUTH/2134/6/08
Data & Publications Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Janssen-Cilag Ltd — Lyrinel XL (oxybutynin hydrochloride)
A pharmacist complained about a Janssen-Cilag Ltd advertisement for Lyrinel XL (oxybutynin hydrochloride) (ref LYR/08-0036) placed in GP, 6 June (Janssen-Cilag stated it was published in Pulse, 4 J…
Clauses: 7.2,7.8
🔒 Subscribers only
AUTH/2135/6/08
Data & Publications Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Bayer Schering Pharma — Betaferon (interferon beta-1b)
An anaesthetist complained about an advertisement placed in The Economist (week of 23 June) by Bayer Schering Pharma.The advertisement was headed “Fighting Multiple Sclerosis” and included the …
Clauses: 20.1,20.2,9.1,2
1 2 Next → Page 1 of 2 — 31 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews